| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038055919 |
| P356 | DOI | 10.1186/1476-4598-9-91 |
| P932 | PMC publication ID | 2873441 |
| P698 | PubMed publication ID | 20426806 |
| P5875 | ResearchGate publication ID | 43350884 |
| P2093 | author name string | Li-Ting Chien | |
| Chin-Tin Chen | |||
| Hong-Tai Ji | |||
| Hsiung-Fei Chien | |||
| Yu-Hsin Lin | |||
| P2860 | cites work | Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy | Q40321304 |
| AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes | Q40336306 | ||
| Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells | Q40344982 | ||
| AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase | Q40657762 | ||
| Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells | Q40707175 | ||
| Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy | Q41003785 | ||
| Characterization of the mucin differentiation in human lung adenocarcinoma cell lines | Q41610423 | ||
| Photodynamic therapy mediates immediate loss of cellular responsiveness to cytokines and growth factors. | Q42163148 | ||
| The role of the peripheral benzodiazepine receptor in the apoptotic response to photodynamic therapy. | Q43730942 | ||
| Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation. | Q53665783 | ||
| Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. | Q55064927 | ||
| AMP-activated Protein Kinase and the Regulation of Autophagic Proteolysis | Q56777095 | ||
| Inhibition of glucocorticoid-induced apoptosis with 5-aminoimidazole-4-carboxamide ribonucleoside, a cell-permeable activator of AMP-activated protein kinase | Q74311172 | ||
| Photodynamic therapy | Q74688364 | ||
| Photodynamic therapy: a mitochondrial inducer of apoptosis | Q77315778 | ||
| Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 | ||
| The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes | Q24290792 | ||
| The AMP-activated protein kinase--fuel gauge of the mammalian cell? | Q24315074 | ||
| Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor | Q24561804 | ||
| LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing | Q24597817 | ||
| Biosynthesis of delta-aminolevulinic acid and the regulation of heme formation by immature erythroid cells in man | Q28678681 | ||
| Autophagy in cell death: an innocent convict? | Q29617604 | ||
| The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis | Q29622875 | ||
| Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells. | Q31039596 | ||
| Hyperresistance to photosensitized lipid peroxidation and apoptotic killing in 5-aminolevulinate-treated tumor cells overexpressing mitochondrial GPX4. | Q33185113 | ||
| Reorganization of cytoskeleton induced by 5-aminolevulinic acid-mediated photodynamic therapy and its correlation with mitochondrial dysfunction. | Q33214457 | ||
| Initiation of apoptosis and autophagy by photodynamic therapy | Q33239933 | ||
| Dealing with energy demand: the AMP-activated protein kinase | Q33543966 | ||
| Photodynamic therapy for cancer | Q34194073 | ||
| Management of cellular energy by the AMP-activated protein kinase system | Q34209246 | ||
| The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. | Q34859478 | ||
| The role of apoptosis in response to photodynamic therapy: what, where, why, and how. | Q35092776 | ||
| Methods for monitoring autophagy | Q35869399 | ||
| Intracellular signaling mechanisms in photodynamic therapy | Q35885684 | ||
| Properties and applications of photodynamic therapy. | Q35897172 | ||
| Autophagy: dual roles in life and death? | Q36146947 | ||
| Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain | Q36475846 | ||
| Autophagy, mitochondrial quality control, and oncogenesis | Q36549509 | ||
| Molecular effectors of multiple cell death pathways initiated by photodynamic therapy | Q36907982 | ||
| AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury | Q37286204 | ||
| Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L. | Q39972651 | ||
| Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity | Q40259774 | ||
| Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines | Q40278287 | ||
| P921 | main subject | aminolevulinic acid | Q238474 |
| autophagy | Q288322 | ||
| cell death | Q2383867 | ||
| P304 | page(s) | 91 | |
| P577 | publication date | 2010-04-28 | |
| P1433 | published in | Molecular Cancer | Q15724585 |
| P1476 | title | 5-ALA mediated photodynamic therapy induces autophagic cell death via AMP-activated protein kinase | |
| P478 | volume | 9 |
| Q99566290 | 9-phenyl acridine photosensitizes A375 cells to UVA radiation |
| Q94188972 | Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer |
| Q57273332 | Amphiphilic chitosan modified upconversion nanoparticles for in vivo photodynamic therapy induced by near-infrared light |
| Q36859217 | Apoptosis and autophagy induced by pyropheophorbide-α methyl ester-mediated photodynamic therapy in human osteosarcoma MG-63 cells |
| Q38202871 | Autophagy Contributes to the Death/Survival Balance in Cancer PhotoDynamic Therapy. |
| Q38349813 | Autophagy, a major adaptation pathway shaping cancer cell death and anticancer immunity responses following photodynamic therapy |
| Q34549203 | Chloride intracellular channel 4 involves in the reduced invasiveness of cancer cells treated by photodynamic therapy. |
| Q33739471 | Doxycycline potentiates antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells |
| Q94457800 | Enhanced anti-tumor efficacy of 5-aminolevulinic acid-gold nanoparticles-mediated photodynamic therapy in cutaneous squamous cell carcinoma cells |
| Q50448694 | Ex vivo evaluation of the effect of photodynamic therapy on skin scars and striae distensae. |
| Q46831195 | HMME-based PDT restores expression and function of transporter associated with antigen processing 1 (TAP1) and surface presentation of MHC class I antigen in human glioma |
| Q39251853 | Light fractionated ALA-PDT enhances therapeutic efficacy in vitro; the influence of PpIX concentration and illumination parameters |
| Q35386782 | Magnetic-luminescent YbPO4:Er,Dy microspheres designed for tumor theranostics with synergistic effect of photodynamic therapy and chemotherapy. |
| Q40979804 | Metformin enhances the cytotoxicity of 5-aminolevulinic acid-mediated photodynamic therapy in vitro |
| Q34068201 | Photochemical internalization of tumor-targeted protein toxins. |
| Q39125005 | Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy |
| Q33713297 | Use of the dietary supplement 5-aminiolevulinic acid (5-ALA) and its relationship with glucose levels and hemoglobin A1C among individuals with prediabetes |
Search more.